| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $40.0B | $43.0B | $44.6B | — | $55.0B | $38.5B | $43.0B |
| Cost of Revenue | $37.4B | $38.4B | $39.7B | $48.3B | $44.2B | $9.1B | $8.7B |
| Gross Profit | — | — | — | — | — | $1.6B | $1.5B |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $1.6B | $1.6B | $1.7B | $1.6B | $1.5B | $1.6B |
| Operating Income | — | — | — | — | — | — | — |
| Net Income | $-2.4B | $1.2B | $0.7B | $4.6B | $6.4B | $1.3B | $-2.3B |
| EPS (Basic) | $-3.70 | $1.57 | $0.82 | $6.32 | $8.44 | $1.64 | $-1.84 |
| EPS (Diluted) | $-3.70 | $1.57 | $0.82 | $6.28 | $8.38 | $1.64 | $-1.84 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $58.5B | $57.3B | $58.0B | $60.6B | $63.0B | $61.5B | $60.5B |
| Current Assets | $18.1B | $16.6B | $17.6B | $20.5B | $20.8B | $19.1B | $16.8B |
| Cash & Equivalents | $3.8B | $2.2B | $3.0B | $3.9B | $3.0B | $5.1B | $2.4B |
| Total Liabilities | — | — | — | — | — | — | — |
| Current Liabilities | $9.2B | $10.3B | $10.0B | $11.3B | $13.2B | $11.1B | $10.7B |
| Stockholders' Equity | $16.0B | $17.4B | $18.6B | $20.7B | $18.2B | $12.4B | $13.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $2.9B | $5.2B | $7.5B | $7.0B | $6.2B | $5.9B |
| Investing Cash Flow | $-2.1B | $-2.4B | $-2.9B | $-3.0B | $-2.9B | $-0.8B | $-2.2B |
| Capital Expenditures | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.5B | $-1.2B | $-3.1B | $-3.4B | $-6.1B | $-2.8B | $-4.1B |